Current immunosuppressive/anti-inflammatory agents target the immune response at the cellular level (T and B cells) or attempt to block cytokines and other mediators ...

Monoclonal antibodies against CD3, CD4, CD8, CD83, CD45, CD45RO, CD19, CD57, CD11c, monokine induced by interferon-γ, vascular endothelial growth factor, and cytokeratins 8 and 18 and polyclonal ...

As over a dozen vaccines are being rolled out worldwide, to protect against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and many more are still being developed, it is ...

Because CD45 is found on healthy blood cells too, the research team used CRISPR base-editing to develop a method called "epitope editing" to overcome the challenges of an anti-CD45 strategy, which ...

VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced new data on its PSMA x CD3 T-cell engagers (TCEs), presented as a poster at the American Association for ...

“Magenta is developing targeted medicines such as CD45-ADC and MGTA-145 to revolutionize the immune reset process and enable more selected patients with autoimmune diseases to undergo a one ...

BOSTON, June 24, 2021 /PRNewswire/ -- Luye Pharma Group's subsidiary Boan Biotech recently published research results for its innovative in-house bispecific antibody BA1202 (CEA/CD3 bispecific T ...

In the study, published today in Science Translational Medicine, the researchers used engineered CAR T cells to target CD45 - a surface marker found on nearly all blood cells, including nearly all ...